210 related articles for article (PubMed ID: 8923290)
1. Measles immunity and response to revaccination of a young adult population in Israel.
Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T
J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290
[TBL] [Abstract][Full Text] [Related]
2. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
[TBL] [Abstract][Full Text] [Related]
3. Measles seroepidemiology among adolescents and young adults: response to revaccination.
Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
[TBL] [Abstract][Full Text] [Related]
4. Determination of immunity to measles virus in young adults: comparative evaluation of a commercial enzyme immunoassay and the hemagglutination inhibition techniques.
Duvdevani P; Varsano N; Slepon R; Lerman Y; Shohat T; Mendelson E
Clin Diagn Virol; 1996 Oct; 7(1):1-6. PubMed ID: 9077425
[TBL] [Abstract][Full Text] [Related]
5. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of measles serodiagnosis during an outbreak in a vaccinated community.
Sekla L; Stackiw W; Eibisch G; Johnson I
Clin Invest Med; 1988 Aug; 11(4):304-9. PubMed ID: 3168353
[TBL] [Abstract][Full Text] [Related]
7. [A study on measles immune status by ELISA].
Li GQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Apr; 10(2):105-8. PubMed ID: 2736614
[TBL] [Abstract][Full Text] [Related]
8. Measles immunity in Israeli young adults: effects of second immunization at 18 years of age.
Olsha M; Mendelson E; Shohat T; Cohen D; Duvdevani P; Lerman Y; Danon YL
Isr J Med Sci; 1994 Aug; 30(8):596-9. PubMed ID: 8045739
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
de Serres G; Boulianne N; Ratnam S; Corriveau A
Pediatrics; 1996 Feb; 97(2):232-5. PubMed ID: 8584383
[TBL] [Abstract][Full Text] [Related]
10. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine.
abu Eldan J; Borćić B; Smerdel S
Acta Med Croatica; 1991; 45(4-5):297-304. PubMed ID: 1726513
[TBL] [Abstract][Full Text] [Related]
11. [Study on the immunization effect of measles vaccine by capture-EIA].
Fang H
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):297-9. PubMed ID: 1300252
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
[TBL] [Abstract][Full Text] [Related]
13. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
Wong-Chew RM; Beeler JA; Audet S; Santos JI
J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117
[TBL] [Abstract][Full Text] [Related]
14. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
15. Development of a new neutralization test for measles virus.
Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
[TBL] [Abstract][Full Text] [Related]
16. [Antibodies to measles virus in blood sera of individuals who were not verified as having been infected with the virus (years 1984-1989)].
Gut W; Litwińska B
Przegl Epidemiol; 1991; 45(3):147-56. PubMed ID: 1819809
[TBL] [Abstract][Full Text] [Related]
17. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M
Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978
[TBL] [Abstract][Full Text] [Related]
18. Immune response to measles vaccine after mass vaccination in Urmia, Islamic Republic of Iran.
Yekta Z; Pourali R; Taravati MR; Shahabi S; Salary S; Khalily F; Farzin A
East Mediterr Health J; 2009; 15(3):516-25. PubMed ID: 19731767
[TBL] [Abstract][Full Text] [Related]
19. Determination of measles hemagglutination inhibiting antibody levels among school children in Ibadan, Nigeria.
Ogundiji OT; Okonko IO; Adu FD
J Immunoassay Immunochem; 2013; 34(2):208-17. PubMed ID: 23537304
[TBL] [Abstract][Full Text] [Related]
20. Measles epidemiology and its implications for a vaccination programme in Oman.
Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
